1965
DOI: 10.1161/01.cir.31.2.219
|View full text |Cite
|
Sign up to set email alerts
|

Catecholamine Depletion in Thyrotoxicosis

Abstract: AN INTIMATE relationship between the sympathetic nervous system and the cardiovascular effects of thyroid hormone has been extensively documented during the past several decades.'-9 In hyperthyroidism in both

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1967
1967
1972
1972

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 39 publications
(2 citation statements)
references
References 24 publications
0
2
0
Order By: Relevance
“…for further references), 1956 (in dogs); Wurtman, Kopin & Axelrod, 1963 (in rats)). It has also been suggested that increased background sympathetic activity may develop rather than sensitization of receptors, since heart rates in thyrotoxic patients and animals were immediately reduced by sympatholytic procedures (spinal anaesthesia (Brewster et al 1956); reserpine (Thier, Gravenstein & Hoffman, 1962); guanethidine (Goldstein & Killip, 1965); propranolol (Howitt & Rowlands, 1966); oxprenolol (Turner & Hill, 1968;Darsinos, Katsilambros, Papamatheou & Papadoyanakis, 1968)).…”
Section: Discussionmentioning
confidence: 99%
“…for further references), 1956 (in dogs); Wurtman, Kopin & Axelrod, 1963 (in rats)). It has also been suggested that increased background sympathetic activity may develop rather than sensitization of receptors, since heart rates in thyrotoxic patients and animals were immediately reduced by sympatholytic procedures (spinal anaesthesia (Brewster et al 1956); reserpine (Thier, Gravenstein & Hoffman, 1962); guanethidine (Goldstein & Killip, 1965); propranolol (Howitt & Rowlands, 1966); oxprenolol (Turner & Hill, 1968;Darsinos, Katsilambros, Papamatheou & Papadoyanakis, 1968)).…”
Section: Discussionmentioning
confidence: 99%
“…Previous reports have been exclusively concerned with the effect upon heart rate, blood pressure and cardiac output. A reduction of all these parameters has been almost uniformly achieved with Guanethidine, the currently most popular sympathetic ganglionic blocking agent (7, 9,14,32). Common to all the above-mentioned works is the lack of a normal control group.…”
Section: (26)mentioning
confidence: 99%